-
1
-
-
85012886951
-
Liquid biopsies, what we do not know (yet)
-
Bardelli A, Pantel K. Liquid biopsies, what we do not know (yet). Cancer Cell. 2017; 31:172-179
-
(2017)
Cancer Cell
, vol.31
, pp. 172-179
-
-
Bardelli, A.1
Pantel, K.2
-
3
-
-
79953251447
-
Prediction of response in cancer immunotherapy
-
Characiejus D, Jacobs JJ, Pasukoniene V, Kazlauskaite N, Danileviciute V, Mauricas M, Den Otter W. Prediction of response in cancer immunotherapy. Anticancer Res. 2011; 31:639-647
-
(2011)
Anticancer Res
, vol.31
, pp. 639-647
-
-
Characiejus, D.1
Jacobs, J.J.2
Pasukoniene, V.3
Kazlauskaite, N.4
Danileviciute, V.5
Mauricas, M.6
Den Otter, W.7
-
4
-
-
84947784661
-
Building a roadmap to biomarker qualification: challenges and opportunities
-
Amur SG, Sanyal S, Chakravarty AG, Noone MH, Kaiser J, McCune S, Buckman-Garner SY. Building a roadmap to biomarker qualification: challenges and opportunities. Biomark Med. 2015; 9:1095-1105
-
(2015)
Biomark Med
, vol.9
, pp. 1095-1105
-
-
Amur, S.G.1
Sanyal, S.2
Chakravarty, A.G.3
Noone, M.H.4
Kaiser, J.5
McCune, S.6
Buckman-Garner, S.Y.7
-
5
-
-
84959563794
-
Next-generation sequencing and immunotherapy biomarkers: a medical oncology perspective
-
Bernicker E. Next-generation sequencing and immunotherapy biomarkers: a medical oncology perspective. Arch Pathol Lab Med. 2016; 140:245-248
-
(2016)
Arch Pathol Lab Med
, vol.140
, pp. 245-248
-
-
Bernicker, E.1
-
6
-
-
84988693250
-
Hunting for the ultimate liquid cancer biopsy-let the TEP dance begin
-
Feller SM, Lewitzky M. Hunting for the ultimate liquid cancer biopsy-let the TEP dance begin. Cell Commun Signal. 2016; 14:24
-
(2016)
Cell Commun Signal
, vol.14
, pp. 24
-
-
Feller, S.M.1
Lewitzky, M.2
-
7
-
-
84943555630
-
CANCER. The odds of immunotherapy success
-
Gubin MM, Schreiber RD. CANCER. The odds of immunotherapy success. Science. 2015; 350:158-159
-
(2015)
Science
, vol.350
, pp. 158-159
-
-
Gubin, M.M.1
Schreiber, R.D.2
-
9
-
-
81055146762
-
Harmonization of immune biomarker assays for clinical studies
-
van der Burg SH, Kalos M, Gouttefangeas C, Janetzki S, Ottensmeier C, Welters MJ, Romero P, Britten CM, Hoos A. Harmonization of immune biomarker assays for clinical studies. Sci Transl Med. 2011; 3:108ps144
-
(2011)
Sci Transl Med
, vol.3
-
-
van der Burg, S.H.1
Kalos, M.2
Gouttefangeas, C.3
Janetzki, S.4
Ottensmeier, C.5
Welters, M.J.6
Romero, P.7
Britten, C.M.8
Hoos, A.9
-
10
-
-
85006626463
-
Cancer precision medicine: from cancer screening to drug selection and personalized immunotherapy
-
Deng X, Nakamura Y. Cancer precision medicine: from cancer screening to drug selection and personalized immunotherapy. Trends Pharmacol Sci. 2017; 38:15-24
-
(2017)
Trends Pharmacol Sci
, vol.38
, pp. 15-24
-
-
Deng, X.1
Nakamura, Y.2
-
11
-
-
85007211490
-
Liquid biopsy for early detection of lung cancer
-
Hofman P. Liquid biopsy for early detection of lung cancer. Curr Opin Oncol. 2017; 29:73-78
-
(2017)
Curr Opin Oncol
, vol.29
, pp. 73-78
-
-
Hofman, P.1
-
12
-
-
84983445246
-
Pathologists and liquid biopsies: to be or not to be?
-
Hofman P, Popper HH. Pathologists and liquid biopsies: to be or not to be? Virchows Arch. 2016; 469:601-609
-
(2016)
Virchows Arch
, vol.469
, pp. 601-609
-
-
Hofman, P.1
Popper, H.H.2
-
13
-
-
85015222262
-
Liquid biopsy genotyping in lung cancer: ready for clinical utility?
-
Huang WL, Chen YL, Yang SC, Ho CL, Wei F, Wong DT, Su WC, Lin CC. Liquid biopsy genotyping in lung cancer: ready for clinical utility? Oncotarget. 2017; 8:18590-18608. doi: 10.18632/oncotarget.14613
-
(2017)
Oncotarget
, vol.8
, pp. 18590-18608
-
-
Huang, W.L.1
Chen, Y.L.2
Yang, S.C.3
Ho, C.L.4
Wei, F.5
Wong, D.T.6
Su, W.C.7
Lin, C.C.8
-
14
-
-
85017685132
-
Emerging role of micrornas as liquid biopsy biomarkers in gastrointestinal cancers
-
Jan 31 [Epub ahead of print]
-
Shigeyasu K, Toden S, Zumwalt TJ, Okugawa Y, Goel A. Emerging role of micrornas as liquid biopsy biomarkers in gastrointestinal cancers. Clin Cancer Res. 2017 Jan 31. doi: 10.1158/1078-0432.CCR-16-1676. [Epub ahead of print]
-
(2017)
Clin Cancer Res
-
-
Shigeyasu, K.1
Toden, S.2
Zumwalt, T.J.3
Okugawa, Y.4
Goel, A.5
-
16
-
-
84976420363
-
Vesicle-MaNiA: extracellular vesicles in liquid biopsy and cancer
-
Torrano V, Royo F, Peinado H, Loizaga-Iriarte A, Unda M, Falcon-Perez JM, Carracedo A. Vesicle-MaNiA: extracellular vesicles in liquid biopsy and cancer. Curr Opin Pharmacol. 2016; 29:47-53
-
(2016)
Curr Opin Pharmacol
, vol.29
, pp. 47-53
-
-
Torrano, V.1
Royo, F.2
Peinado, H.3
Loizaga-Iriarte, A.4
Unda, M.5
Falcon-Perez, J.M.6
Carracedo, A.7
-
17
-
-
85018667324
-
The feasibility of using mutation detection in ctDNA to assess tumor dynamics
-
Yi X, Ma J, Guan Y, Chen R, Yang L, Xia X. The feasibility of using mutation detection in ctDNA to assess tumor dynamics. Int J Cancer. 2017; 140:2642-2647
-
(2017)
Int J Cancer
, vol.140
, pp. 2642-2647
-
-
Yi, X.1
Ma, J.2
Guan, Y.3
Chen, R.4
Yang, L.5
Xia, X.6
-
18
-
-
84962430694
-
Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery
-
Nawaz M, Fatima F, Nazarenko I, Ekstrom K, Murtaza I, Anees M, Sultan A, Neder L, Camussi G, Valadi H, Squire JA, Kislinger T. Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery. Expert Rev Proteomics. 2016; 13:395-409
-
(2016)
Expert Rev Proteomics
, vol.13
, pp. 395-409
-
-
Nawaz, M.1
Fatima, F.2
Nazarenko, I.3
Ekstrom, K.4
Murtaza, I.5
Anees, M.6
Sultan, A.7
Neder, L.8
Camussi, G.9
Valadi, H.10
Squire, J.A.11
Kislinger, T.12
-
19
-
-
84966318628
-
Proteomic analysis of exosomal cargo: the challenge of high purity vesicle isolation
-
Abramowicz A, Widlak P, Pietrowska M. Proteomic analysis of exosomal cargo: the challenge of high purity vesicle isolation. Mol Biosyst. 2016; 12:1407-1419
-
(2016)
Mol Biosyst
, vol.12
, pp. 1407-1419
-
-
Abramowicz, A.1
Widlak, P.2
Pietrowska, M.3
-
20
-
-
84943329505
-
Characterization of RNA from exosomes and other extracellular vesicles isolated by a novel spin column-based method
-
Enderle D, Spiel A, Coticchia CM, Berghoff E, Mueller R, Schlumpberger M, Sprenger-Haussels M, Shaffer JM, Lader E, Skog J, Noerholm M. Characterization of RNA from exosomes and other extracellular vesicles isolated by a novel spin column-based method. PLoS One. 2015; 10:e0136133
-
(2015)
PLoS One
, vol.10
-
-
Enderle, D.1
Spiel, A.2
Coticchia, C.M.3
Berghoff, E.4
Mueller, R.5
Schlumpberger, M.6
Sprenger-Haussels, M.7
Shaffer, J.M.8
Lader, E.9
Skog, J.10
Noerholm, M.11
-
21
-
-
84936980504
-
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
-
Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari N, Reissfelder C, Pilarsky C, Fraga MF, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015; 523:177-182
-
(2015)
Nature
, vol.523
, pp. 177-182
-
-
Melo, S.A.1
Luecke, L.B.2
Kahlert, C.3
Fernandez, A.F.4
Gammon, S.T.5
Kaye, J.6
LeBleu, V.S.7
Mittendorf, E.A.8
Weitz, J.9
Rahbari, N.10
Reissfelder, C.11
Pilarsky, C.12
Fraga, M.F.13
-
23
-
-
84943557102
-
Liquid biopsy: its impact on cancer diagnostics
-
Menzel C, Kazinski M. Liquid biopsy: its impact on cancer diagnostics. MLO Med Lab Obs. 2015; 47:27-28
-
(2015)
MLO Med Lab Obs
, vol.47
, pp. 27-28
-
-
Menzel, C.1
Kazinski, M.2
-
24
-
-
84958740825
-
therascreen ((R)) EGFR RGQ PCR Kit: a companion diagnostic for afatinib and gefitinib in nonsmall cell lung cancer
-
Syed YY. therascreen ((R)) EGFR RGQ PCR Kit: a companion diagnostic for afatinib and gefitinib in nonsmall cell lung cancer. Mol Diagn Ther. 2016; 20:191-198
-
(2016)
Mol Diagn Ther
, vol.20
, pp. 191-198
-
-
Syed, Y.Y.1
-
25
-
-
84906250256
-
Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR status
-
Douillard JY, Ostoros G, Cobo M, Ciuleanu T, Cole R, McWalter G, Walker J, Dearden S, Webster A, Milenkova T, McCormack R. Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR status. J Thorac Oncol. 2014; 9:1345-1353
-
(2014)
J Thorac Oncol
, vol.9
, pp. 1345-1353
-
-
Douillard, J.Y.1
Ostoros, G.2
Cobo, M.3
Ciuleanu, T.4
Cole, R.5
McWalter, G.6
Walker, J.7
Dearden, S.8
Webster, A.9
Milenkova, T.10
McCormack, R.11
-
26
-
-
84861746437
-
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA
-
Forshew T, Murtaza M, Parkinson C, Gale D, Tsui DW, Kaper F, Dawson SJ, Piskorz AM, Jimenez-Linan M, Bentley D, Hadfield J, May AP, Caldas C, et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Transl Med. 2012; 4:136ra168
-
(2012)
Sci Transl Med
, vol.4
-
-
Forshew, T.1
Murtaza, M.2
Parkinson, C.3
Gale, D.4
Tsui, D.W.5
Kaper, F.6
Dawson, S.J.7
Piskorz, A.M.8
Jimenez-Linan, M.9
Bentley, D.10
Hadfield, J.11
May, A.P.12
Caldas, C.13
-
27
-
-
84946559772
-
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
-
Murtaza M, Dawson SJ, Pogrebniak K, Rueda OM, Provenzano E, Grant J, Chin SF, Tsui DW, Marass F, Gale D, Ali HR, Shah P, Contente-Cuomo T, et al. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nat Commun. 2015; 6:8760
-
(2015)
Nat Commun
, vol.6
, pp. 8760
-
-
Murtaza, M.1
Dawson, S.J.2
Pogrebniak, K.3
Rueda, O.M.4
Provenzano, E.5
Grant, J.6
Chin, S.F.7
Tsui, D.W.8
Marass, F.9
Gale, D.10
Ali, H.R.11
Shah, P.12
Contente-Cuomo, T.13
-
28
-
-
84877579861
-
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
-
Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, Parkinson C, Chin SF, Kingsbury Z, Wong AS, Marass F, Humphray S, Hadfield J, et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature. 2013; 497:108-112
-
(2013)
Nature
, vol.497
, pp. 108-112
-
-
Murtaza, M.1
Dawson, S.J.2
Tsui, D.W.3
Gale, D.4
Forshew, T.5
Piskorz, A.M.6
Parkinson, C.7
Chin, S.F.8
Kingsbury, Z.9
Wong, A.S.10
Marass, F.11
Humphray, S.12
Hadfield, J.13
-
29
-
-
84875520648
-
Analysis of circulating tumor DNA to monitor metastatic breast cancer
-
Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B, Rajan S, Humphray S, Becq J, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. New Engl J Med. 2013; 368:1199-1209
-
(2013)
New Engl J Med
, vol.368
, pp. 1199-1209
-
-
Dawson, S.J.1
Tsui, D.W.2
Murtaza, M.3
Biggs, H.4
Rueda, O.M.5
Chin, S.F.6
Dunning, M.J.7
Gale, D.8
Forshew, T.9
Mahler-Araujo, B.10
Rajan, S.11
Humphray, S.12
Becq, J.13
-
30
-
-
51349141191
-
Circulating mutant DNA to assess tumor dynamics
-
Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, Kinzler KW, Vogelstein B, Diaz LA Jr. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008; 14:985-990
-
(2008)
Nat Med
, vol.14
, pp. 985-990
-
-
Diehl, F.1
Schmidt, K.2
Choti, M.A.3
Romans, K.4
Goodman, S.5
Li, M.6
Thornton, K.7
Agrawal, N.8
Sokoll, L.9
Szabo, S.A.10
Kinzler, K.W.11
Vogelstein, B.12
Diaz, L.A.13
-
31
-
-
84969926517
-
Cell-free circulating tumor DNA in cancer
-
Qin Z, Ljubimov VA, Zhou C, Tong Y, Liang J. Cell-free circulating tumor DNA in cancer. Chin J Cancer. 2016; 35:36
-
(2016)
Chin J Cancer
, vol.35
, pp. 36
-
-
Qin, Z.1
Ljubimov, V.A.2
Zhou, C.3
Tong, Y.4
Liang, J.5
-
32
-
-
85018416387
-
Chromosomal instability in cell-free DNA as a highly specific biomarker for detection of ovarian cancer in women with adnexal masses
-
Vanderstichele A, Busschaert P, Smeets D, Landolfo C, Van Nieuwenhuysen E, Leunen K, Neven P, Amant F, Mahner S, Braicu E, Zeilinger R, Coosemans A, Timmerman D. Chromosomal instability in cell-free DNA as a highly specific biomarker for detection of ovarian cancer in women with adnexal masses. Clin Cancer Res. 2016; 23:2223-2231
-
(2016)
Clin Cancer Res
, vol.23
, pp. 2223-2231
-
-
Vanderstichele, A.1
Busschaert, P.2
Smeets, D.3
Landolfo, C.4
Van Nieuwenhuysen, E.5
Leunen, K.6
Neven, P.7
Amant, F.8
Mahner, S.9
Braicu, E.10
Zeilinger, R.11
Coosemans, A.12
Timmerman, D.13
-
33
-
-
67649223912
-
MYC quantitation in cell-free plasma DNA by real-time PCR for gastric cancer diagnosis
-
Park KU, Lee HE, Park do J, Jung EJ, Song J, Kim HH, Choe G, Kim WH, Lee HS. MYC quantitation in cell-free plasma DNA by real-time PCR for gastric cancer diagnosis. Clin Chem Lab Med. 2009; 47:530-536
-
(2009)
Clin Chem Lab Med
, vol.47
, pp. 530-536
-
-
Park, K.U.1
Lee, H.E.2
Park do, J.3
Jung, E.J.4
Song, J.5
Kim, H.H.6
Choe, G.7
Kim, W.H.8
Lee, H.S.9
-
34
-
-
84942111942
-
HER2 amplification detected in the circulating DNA of patients with gastric cancer: a retrospective pilot study
-
Shoda K, Masuda K, Ichikawa D, Arita T, Miyakami Y, Watanabe M, Konishi H, Imoto I, Otsuji E. HER2 amplification detected in the circulating DNA of patients with gastric cancer: a retrospective pilot study. Gastric Cancer. 2015; 18:698-710
-
(2015)
Gastric Cancer
, vol.18
, pp. 698-710
-
-
Shoda, K.1
Masuda, K.2
Ichikawa, D.3
Arita, T.4
Miyakami, Y.5
Watanabe, M.6
Konishi, H.7
Imoto, I.8
Otsuji, E.9
-
36
-
-
84906054474
-
Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial
-
Muller V, Gade S, Steinbach B, Loibl S, von Minckwitz G, Untch M, Schwedler K, Lubbe K, Schem C, Fasching PA, Mau C, Pantel K, Schwarzenbach H. Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial. Breast Cancer Res Treat. 2014; 147:61-68
-
(2014)
Breast Cancer Res Treat
, vol.147
, pp. 61-68
-
-
Muller, V.1
Gade, S.2
Steinbach, B.3
Loibl, S.4
von Minckwitz, G.5
Untch, M.6
Schwedler, K.7
Lubbe, K.8
Schem, C.9
Fasching, P.A.10
Mau, C.11
Pantel, K.12
Schwarzenbach, H.13
-
37
-
-
84946499684
-
Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
-
Meng X, Joosse SA, Muller V, Trillsch F, Milde-Langosch K, Mahner S, Geffken M, Pantel K, Schwarzenbach H. Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients. Br J Cancer. 2015; 113:1358-1366
-
(2015)
Br J Cancer
, vol.113
, pp. 1358-1366
-
-
Meng, X.1
Joosse, S.A.2
Muller, V.3
Trillsch, F.4
Milde-Langosch, K.5
Mahner, S.6
Geffken, M.7
Pantel, K.8
Schwarzenbach, H.9
-
38
-
-
84923699297
-
Increased serum levels of circulating exosomal microRNA-373 in receptornegative breast cancer patients
-
Eichelser C, Stuckrath I, Muller V, Milde-Langosch K, Wikman H, Pantel K, Schwarzenbach H. Increased serum levels of circulating exosomal microRNA-373 in receptornegative breast cancer patients. Oncotarget. 2014; 5:9650-9663 doi: 10.18632/oncotarget.2520
-
(2014)
Oncotarget
, vol.5
, pp. 9650-9663
-
-
Eichelser, C.1
Stuckrath, I.2
Muller, V.3
Milde-Langosch, K.4
Wikman, H.5
Pantel, K.6
Schwarzenbach, H.7
-
39
-
-
84857968441
-
The majority of microRNAs detectable in serum and saliva is concentrated in exosomes
-
Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One. 2012; 7:e30679
-
(2012)
PLoS One
, vol.7
-
-
Gallo, A.1
Tandon, M.2
Alevizos, I.3
Illei, G.G.4
-
40
-
-
79953202200
-
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
-
Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011; 108:5003-5008
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 5003-5008
-
-
Arroyo, J.D.1
Chevillet, J.R.2
Kroh, E.M.3
Ruf, I.K.4
Pritchard, C.C.5
Gibson, D.F.6
Mitchell, P.S.7
Bennett, C.F.8
Pogosova-Agadjanyan, E.L.9
Stirewalt, D.L.10
Tait, J.F.11
Tewari, M.12
-
41
-
-
84964700391
-
Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy
-
Alix-Panabieres C, Pantel K. Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Cancer discovery. 2016; 6:479-491
-
(2016)
Cancer discovery
, vol.6
, pp. 479-491
-
-
Alix-Panabieres, C.1
Pantel, K.2
-
42
-
-
84962412828
-
A multicenter trial defining a serum protein signature associated with pancreatic ductal adenocarcinoma
-
Gerdtsson AS, Malats N, Sall A, Real FX, Porta M, Skoog P, Persson H, Wingren C, Borrebaeck CA. A multicenter trial defining a serum protein signature associated with pancreatic ductal adenocarcinoma. Int J Proteomics. 2015; 2015:587250
-
(2015)
Int J Proteomics
, vol.2015
-
-
Gerdtsson, A.S.1
Malats, N.2
Sall, A.3
Real, F.X.4
Porta, M.5
Skoog, P.6
Persson, H.7
Wingren, C.8
Borrebaeck, C.A.9
-
43
-
-
84877076923
-
From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer
-
Angell H, Galon J. From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer. Curr Opin Immunol. 2013; 25:261-267
-
(2013)
Curr Opin Immunol
, vol.25
, pp. 261-267
-
-
Angell, H.1
Galon, J.2
-
44
-
-
79953251570
-
Prognostic significance of peripheral blood CD8highCD57+ lymphocytes in bladder carcinoma patients after intravesical IL-2
-
Characiejus D, Pasukoniene V, Jacobs JJ, Eidukevicius R, Jankevicius F, Dobrovolskiene N, Mauricas M, Van Moorselaar RJ, Den Otter W. Prognostic significance of peripheral blood CD8highCD57+ lymphocytes in bladder carcinoma patients after intravesical IL-2. Anticancer Res. 2011; 31:699-703
-
(2011)
Anticancer Res
, vol.31
, pp. 699-703
-
-
Characiejus, D.1
Pasukoniene, V.2
Jacobs, J.J.3
Eidukevicius, R.4
Jankevicius, F.5
Dobrovolskiene, N.6
Mauricas, M.7
Van Moorselaar, R.J.8
Den Otter, W.9
-
45
-
-
0141535454
-
Clonal cytotoxic T cells in myeloma
-
Sze DM, Brown RD, Yuen E, Gibson J, Ho J, Raitakari M, Basten A, Joshua DE, Fazekas de St Groth B. Clonal cytotoxic T cells in myeloma. Leuk Lymphoma. 2003; 44:1667-1674
-
(2003)
Leuk Lymphoma
, vol.44
, pp. 1667-1674
-
-
Sze, D.M.1
Brown, R.D.2
Yuen, E.3
Gibson, J.4
Ho, J.5
Raitakari, M.6
Basten, A.7
Joshua, D.E.8
Fazekas de St Groth, B.9
-
46
-
-
84977071041
-
Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients
-
Everson RG, Jin RM, Wang X, Safaee M, Scharnweber R, Lisiero DN, Soto H, Liau LM, Prins RM. Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients. J Immunother Cancer. 2014; 2:10
-
(2014)
J Immunother Cancer
, vol.2
, pp. 10
-
-
Everson, R.G.1
Jin, R.M.2
Wang, X.3
Safaee, M.4
Scharnweber, R.5
Lisiero, D.N.6
Soto, H.7
Liau, L.M.8
Prins, R.M.9
-
47
-
-
84943516465
-
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
-
Van Allen EM, Miao D, Schilling B, Shukla SA, Blank C, Zimmer L, Sucker A, Hillen U, Foppen MH, Goldinger SM, Utikal J, Hassel JC, Weide B, et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science. 2015; 350:207-211
-
(2015)
Science
, vol.350
, pp. 207-211
-
-
Van Allen, E.M.1
Miao, D.2
Schilling, B.3
Shukla, S.A.4
Blank, C.5
Zimmer, L.6
Sucker, A.7
Hillen, U.8
Foppen, M.H.9
Goldinger, S.M.10
Utikal, J.11
Hassel, J.C.12
Weide, B.13
-
49
-
-
85047692172
-
Therapeutic vaccines for cancer: an overview of clinical trials
-
Melero I, Gaudernack G, Gerritsen W, Huber C, Parmiani G, Scholl S, Thatcher N, Wagstaff J, Zielinski C, Faulkner I, Mellstedt H. Therapeutic vaccines for cancer: an overview of clinical trials. Nat Rev Clin Oncol. 2014; 11:509-524
-
(2014)
Nat Rev Clin Oncol
, vol.11
, pp. 509-524
-
-
Melero, I.1
Gaudernack, G.2
Gerritsen, W.3
Huber, C.4
Parmiani, G.5
Scholl, S.6
Thatcher, N.7
Wagstaff, J.8
Zielinski, C.9
Faulkner, I.10
Mellstedt, H.11
-
50
-
-
84963621254
-
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
-
Topalian SL, Taube JM, Anders RA, Pardoll DM. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat Rev Cancer. 2016; 16:275-287
-
(2016)
Nat Rev Cancer
, vol.16
, pp. 275-287
-
-
Topalian, S.L.1
Taube, J.M.2
Anders, R.A.3
Pardoll, D.M.4
-
51
-
-
85024363237
-
-
SPIDIA. http://www.spidia.eu
-
-
-
-
52
-
-
85024405094
-
-
CANCER. http://www.cancer-id.eu
-
-
-
-
53
-
-
84900437156
-
Harmonization: the sample, the measurement, and the report
-
Miller WG, Tate JR, Barth JH, Jones GR. Harmonization: the sample, the measurement, and the report. Ann Lab Med. 2014; 34:187-197
-
(2014)
Ann Lab Med
, vol.34
, pp. 187-197
-
-
Miller, W.G.1
Tate, J.R.2
Barth, J.H.3
Jones, G.R.4
-
54
-
-
37349020262
-
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
-
Janetzki S, Panageas KS, Ben-Porat L, Boyer J, Britten CM, Clay TM, Kalos M, Maecker HT, Romero P, Yuan J, Kast WM, Hoos A; Elispot Proficiency Panel of the CVCIAWG. Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunol Immunother. 2008; 57:303-315
-
(2008)
Cancer Immunol Immunother
, vol.57
, pp. 303-315
-
-
Janetzki, S.1
Panageas, K.S.2
Ben-Porat, L.3
Boyer, J.4
Britten, C.M.5
Clay, T.M.6
Kalos, M.7
Maecker, H.T.8
Romero, P.9
Yuan, J.10
Kast, W.M.11
Hoos, A.12
-
55
-
-
84945931314
-
Prognostic and predictive biomarkers in colorectal cancer. From the preclinical setting to clinical practice
-
Maurel J, Postigo A. Prognostic and predictive biomarkers in colorectal cancer. From the preclinical setting to clinical practice. Curr Cancer Drug Targets. 2015; 15:703-715
-
(2015)
Curr Cancer Drug Targets
, vol.15
, pp. 703-715
-
-
Maurel, J.1
Postigo, A.2
-
56
-
-
85010369646
-
Bringing 3D tumor models to the clinic-predictive value for personalized medicine
-
Epub 2017 Jan 18
-
Halfter K, Mayer B. Bringing 3D tumor models to the clinic-predictive value for personalized medicine. Biotechnol J. 2017; 12. doi: 10.1002/biot.201600295. Epub 2017 Jan 18
-
(2017)
Biotechnol J
, pp. 12
-
-
Halfter, K.1
Mayer, B.2
-
57
-
-
84945565935
-
The future of patient-derived tumor xenografts in cancer treatment
-
Sia D, Moeini A, Labgaa I, Villanueva A. The future of patient-derived tumor xenografts in cancer treatment. Pharmacogenomics. 2015; 16:1671-1683
-
(2015)
Pharmacogenomics
, vol.16
, pp. 1671-1683
-
-
Sia, D.1
Moeini, A.2
Labgaa, I.3
Villanueva, A.4
-
58
-
-
84899752915
-
Development of an innovative 3D cell culture system to study tumour-stroma interactions in non-small cell lung cancer cells
-
Amann A, Zwierzina M, Gamerith G, Bitsche M, Huber JM, Vogel GF, Blumer M, Koeck S, Pechriggl EJ, Kelm JM, Hilbe W, Zwierzina H. Development of an innovative 3D cell culture system to study tumour-stroma interactions in non-small cell lung cancer cells. PLoS One. 2014; 9:e92511
-
(2014)
PLoS One
, vol.9
-
-
Amann, A.1
Zwierzina, M.2
Gamerith, G.3
Bitsche, M.4
Huber, J.M.5
Vogel, G.F.6
Blumer, M.7
Koeck, S.8
Pechriggl, E.J.9
Kelm, J.M.10
Hilbe, W.11
Zwierzina, H.12
-
59
-
-
84960517008
-
Infiltration of lymphocyte subpopulations into cancer microtissues as a tool for the exploration of immunomodulatory agents and biomarkers
-
Koeck S, Zwierzina M, Huber JM, Bitsche M, Lorenz E, Gamerith G, Dudas J, Kelm JM, Zwierzina H, Amann A. Infiltration of lymphocyte subpopulations into cancer microtissues as a tool for the exploration of immunomodulatory agents and biomarkers. Immunobiology. 2016; 221:604-617
-
(2016)
Immunobiology
, vol.221
, pp. 604-617
-
-
Koeck, S.1
Zwierzina, M.2
Huber, J.M.3
Bitsche, M.4
Lorenz, E.5
Gamerith, G.6
Dudas, J.7
Kelm, J.M.8
Zwierzina, H.9
Amann, A.10
-
60
-
-
84977110484
-
Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies
-
Sanmamed MF, Chester C, Melero I, Kohrt H. Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies. Ann Oncol. 2016; 27:1190-1198
-
(2016)
Ann Oncol
, vol.27
, pp. 1190-1198
-
-
Sanmamed, M.F.1
Chester, C.2
Melero, I.3
Kohrt, H.4
-
61
-
-
85027921354
-
Advancing the global proteome survey platform by using an oriented single chain antibody fragment immobilization approach
-
Sall A, Persson H, Ohlin M, Borrebaeck CA, Wingren C. Advancing the global proteome survey platform by using an oriented single chain antibody fragment immobilization approach. N Biotechnol. 2016; 33:503-513
-
(2016)
N Biotechnol
, vol.33
, pp. 503-513
-
-
Sall, A.1
Persson, H.2
Ohlin, M.3
Borrebaeck, C.A.4
Wingren, C.5
-
62
-
-
84890689655
-
Grading breast cancer tissues using molecular portraits
-
Olsson N, Carlsson P, James P, Hansson K, Waldemarson S, Malmstrom P, Ferno M, Ryden L, Wingren C, Borrebaeck CA. Grading breast cancer tissues using molecular portraits. Mol Cell Proteomics. 2013; 12:3612-3623
-
(2013)
Mol Cell Proteomics
, vol.12
, pp. 3612-3623
-
-
Olsson, N.1
Carlsson, P.2
James, P.3
Hansson, K.4
Waldemarson, S.5
Malmstrom, P.6
Ferno, M.7
Ryden, L.8
Wingren, C.9
Borrebaeck, C.A.10
-
63
-
-
84981747462
-
Plasma protein profiling in a stage defined pancreatic cancer cohort: implications for early diagnosis
-
Gerdtsson AS, Wingren C, Persson H, Delfani P, Nordstrom M, Ren H, Wen X, Ringdahl U, Borrebaeck CA, Hao J. Plasma protein profiling in a stage defined pancreatic cancer cohort: implications for early diagnosis. Mol Oncol. 2016; 10:1305-1316
-
(2016)
Mol Oncol
, vol.10
, pp. 1305-1316
-
-
Gerdtsson, A.S.1
Wingren, C.2
Persson, H.3
Delfani, P.4
Nordstrom, M.5
Ren, H.6
Wen, X.7
Ringdahl, U.8
Borrebaeck, C.A.9
Hao, J.10
-
64
-
-
84981747462
-
Plasma protein profiling in a stage defined pancreatic cancer cohort: implications for early diagnosis
-
Gerdtsson AS, Wingren C, Persson H, Delfani P, Nordström M, Ren H, Wen X, Ringdahl U, Borrebaeck CA, Hao J. Plasma protein profiling in a stage defined pancreatic cancer cohort: implications for early diagnosis. Mol Oncol. 2016; 10:1305-1316
-
(2016)
Mol Oncol
, vol.10
, pp. 1305-1316
-
-
Gerdtsson, A.S.1
Wingren, C.2
Persson, H.3
Delfani, P.4
Nordström, M.5
Ren, H.6
Wen, X.7
Ringdahl, U.8
Borrebaeck, C.A.9
Hao, J.10
-
66
-
-
84959334228
-
Serum autoantibodies in chronic prostate inflammation in prostate cancer patients
-
Chlick B, Massoner P, Lueking A, Charoentong P, Blattner M, Schaefer G, Marquart K, Theek C, Amersdorfer P, Zielinski D, Kirchner M, Trajanoski Z, Rubin MA, et al. Serum autoantibodies in chronic prostate inflammation in prostate cancer patients. PLoS One. 2016; 11:e0147739
-
(2016)
PLoS One
, vol.11
-
-
Chlick, B.1
Massoner, P.2
Lueking, A.3
Charoentong, P.4
Blattner, M.5
Schaefer, G.6
Marquart, K.7
Theek, C.8
Amersdorfer, P.9
Zielinski, D.10
Kirchner, M.11
Trajanoski, Z.12
Rubin, M.A.13
-
67
-
-
84941794352
-
Some imminent but overlooked preanalytical and analytical challenges currently facing biomarkers and companion diagnostics
-
Halim AB. Some imminent but overlooked preanalytical and analytical challenges currently facing biomarkers and companion diagnostics. Ann N Y Acad Sci. 2015; 1346:63-70
-
(2015)
Ann N Y Acad Sci
, vol.1346
, pp. 63-70
-
-
Halim, A.B.1
-
69
-
-
85013854018
-
Liquid biopsies come of age: towards implementation of circulating tumour DNA
-
Wan JC, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, Pacey S, Baird R, Rosenfeld N. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer. 2017; 17:223-238
-
(2017)
Nat Rev Cancer
, vol.17
, pp. 223-238
-
-
Wan, J.C.1
Massie, C.2
Garcia-Corbacho, J.3
Mouliere, F.4
Brenton, J.D.5
Caldas, C.6
Pacey, S.7
Baird, R.8
Rosenfeld, N.9
-
70
-
-
84937611698
-
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
-
Wang Y, Springer S, Mulvey CL, Silliman N, Schaefer J, Sausen M, James N, Rettig EM, Guo T, Pickering CR, Bishop JA, Chung CH, Califano JA, et al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas. Sci Transl Med. 2015; 7:293ra104
-
(2015)
Sci Transl Med
, vol.7
-
-
Wang, Y.1
Springer, S.2
Mulvey, C.L.3
Silliman, N.4
Schaefer, J.5
Sausen, M.6
James, N.7
Rettig, E.M.8
Guo, T.9
Pickering, C.R.10
Bishop, J.A.11
Chung, C.H.12
Califano, J.A.13
-
71
-
-
84959343666
-
Recent advances in salivary cancer diagnostics enabled by biosensors and bioelectronics
-
Mishra S, Saadat D, Kwon O, Lee Y, Choi WS, Kim JH, Yeo WH. Recent advances in salivary cancer diagnostics enabled by biosensors and bioelectronics. Biosens Bioelectron. 2016; 81:181-197
-
(2016)
Biosens Bioelectron
, vol.81
, pp. 181-197
-
-
Mishra, S.1
Saadat, D.2
Kwon, O.3
Lee, Y.4
Choi, W.S.5
Kim, J.H.6
Yeo, W.H.7
-
72
-
-
84930757392
-
Developing proteomic biomarkers for bladder cancer: towards clinical application
-
Frantzi M, Latosinska A, Fluhe L, Hupe MC, Critselis E, Kramer MW, Merseburger AS, Mischak H, Vlahou A. Developing proteomic biomarkers for bladder cancer: towards clinical application. Nat Rev Urol. 2015; 12:317-330
-
(2015)
Nat Rev Urol
, vol.12
, pp. 317-330
-
-
Frantzi, M.1
Latosinska, A.2
Fluhe, L.3
Hupe, M.C.4
Critselis, E.5
Kramer, M.W.6
Merseburger, A.S.7
Mischak, H.8
Vlahou, A.9
-
73
-
-
84994418166
-
Renal cell carcinoma: a critical analysis of metabolomic biomarkers emerging from current model systems
-
Rodrigues D, Monteiro M, Jeronimo C, Henrique R, Belo L, Bastos ML, P GdP, Carvalho M. Renal cell carcinoma: a critical analysis of metabolomic biomarkers emerging from current model systems. Transl Res. 2017; 180:1-11
-
(2017)
Transl Res
, vol.180
, pp. 1-11
-
-
Rodrigues, D.1
Monteiro, M.2
Jeronimo, C.3
Henrique, R.4
Belo, L.5
Bastos, M.L.6
Guedes de Pinho, P.7
Carvalho, M.8
-
74
-
-
84930040109
-
Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: clinical correlates
-
Liao JB, Yip YY, Swisher EM, Agnew K, Hellstrom KE, Hellstrom I. Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: clinical correlates. Gynecolo Oncol. 2015; 137:430-435
-
(2015)
Gynecolo Oncol
, vol.137
, pp. 430-435
-
-
Liao, J.B.1
Yip, Y.Y.2
Swisher, E.M.3
Agnew, K.4
Hellstrom, K.E.5
Hellstrom, I.6
-
75
-
-
85016140999
-
Next generation biomarkers in prostate cancer
-
Locke JA, Black PC. Next generation biomarkers in prostate cancer. Front Biosci. 2016; 21:328-342
-
(2016)
Front Biosci
, vol.21
, pp. 328-342
-
-
Locke, J.A.1
Black, P.C.2
-
76
-
-
85010657768
-
A novel urine exosome gene expression assay to predict highgrade prostate cancer at initial biopsy
-
McKiernan J, Donovan MJ, O'Neill V, Bentink S, Noerholm M, Belzer S, Skog J, Kattan MW, Partin A, Andriole G, Brown G, Wei JT, Thompson IM Jr, Carroll P. A novel urine exosome gene expression assay to predict highgrade prostate cancer at initial biopsy. JAMA Oncol. 2016; 2:882-889
-
(2016)
JAMA Oncol
, vol.2
, pp. 882-889
-
-
McKiernan, J.1
Donovan, M.J.2
O'Neill, V.3
Bentink, S.4
Noerholm, M.5
Belzer, S.6
Skog, J.7
Kattan, M.W.8
Partin, A.9
Andriole, G.10
Brown, G.11
Wei, J.T.12
Thompson, I.M.13
Carroll, P.14
-
77
-
-
84885295979
-
Interferon-gamma in ascites could be a predictive biomarker of outcome in ovarian carcinoma
-
Chen YL, Cheng WF, Chang MC, Lin HW, Huang CT, Chien CL, Chen CA. Interferon-gamma in ascites could be a predictive biomarker of outcome in ovarian carcinoma. Gynec Oncol. 2013; 131:63-68
-
(2013)
Gynec Oncol
, vol.131
, pp. 63-68
-
-
Chen, Y.L.1
Cheng, W.F.2
Chang, M.C.3
Lin, H.W.4
Huang, C.T.5
Chien, C.L.6
Chen, C.A.7
-
78
-
-
85027929550
-
Towards precision medicine in the clinic: from biomarker discovery to novel therapeutics
-
Collins DC, Sundar R, Lim JS, Yap TA. Towards precision medicine in the clinic: from biomarker discovery to novel therapeutics. Trends Pharmacol Sci. 2017; 38:25-40
-
(2017)
Trends Pharmacol Sci
, vol.38
, pp. 25-40
-
-
Collins, D.C.1
Sundar, R.2
Lim, J.S.3
Yap, T.A.4
-
79
-
-
84944472832
-
Molecular classification of gastric cancer: towards a pathway-driven targeted therapy
-
Riquelme I, Saavedra K, Espinoza JA, Weber H, Garcia P, Nervi B, Garrido M, Corvalan AH, Roa JC, Bizama C. Molecular classification of gastric cancer: towards a pathway-driven targeted therapy. Oncotarget. 2015; 6:24750-24779. doi: 10.18632/oncotarget.4990
-
(2015)
Oncotarget
, vol.6
, pp. 24750-24779
-
-
Riquelme, I.1
Saavedra, K.2
Espinoza, J.A.3
Weber, H.4
Garcia, P.5
Nervi, B.6
Garrido, M.7
Corvalan, A.H.8
Roa, J.C.9
Bizama, C.10
-
80
-
-
84865662831
-
Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients
-
Sigalotti L, Covre A, Fratta E, Parisi G, Sonego P, Colizzi F, Coral S, Massarut S, Kirkwood JM, Maio M. Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients. J Transl Med. 2012; 10:185
-
(2012)
J Transl Med
, vol.10
, pp. 185
-
-
Sigalotti, L.1
Covre, A.2
Fratta, E.3
Parisi, G.4
Sonego, P.5
Colizzi, F.6
Coral, S.7
Massarut, S.8
Kirkwood, J.M.9
Maio, M.10
-
81
-
-
84998704798
-
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
-
Feng Z, Puri S, Moudgil T, Wood W, Hoyt CC, Wang C, Urba WJ, Curti BD, Bifulco CB, Fox BA. Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma. J Immunother Cancer. 2015; 3:47
-
(2015)
J Immunother Cancer
, vol.3
, pp. 47
-
-
Feng, Z.1
Puri, S.2
Moudgil, T.3
Wood, W.4
Hoyt, C.C.5
Wang, C.6
Urba, W.J.7
Curti, B.D.8
Bifulco, C.B.9
Fox, B.A.10
-
82
-
-
84976511909
-
PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma
-
Nghiem PT, Bhatia S, Lipson EJ, Kudchadkar RR, Miller NJ, Annamalai L, Berry S, Chartash EK, Daud A, Fling SP, Friedlander PA, Kluger HM, Kohrt HE, et al. PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma. N Engl J Med. 374:2542-2552
-
N Engl J Med
, vol.374
, pp. 2542-2552
-
-
Nghiem, P.T.1
Bhatia, S.2
Lipson, E.J.3
Kudchadkar, R.R.4
Miller, N.J.5
Annamalai, L.6
Berry, S.7
Chartash, E.K.8
Daud, A.9
Fling, S.P.10
Friedlander, P.A.11
Kluger, H.M.12
Kohrt, H.E.13
-
83
-
-
84925186719
-
Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis
-
Stack EC, Wang C, Roman KA, Hoyt CC. Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. Methods. 2014; 70:46-58
-
(2014)
Methods
, vol.70
, pp. 46-58
-
-
Stack, E.C.1
Wang, C.2
Roman, K.A.3
Hoyt, C.C.4
-
84
-
-
84975817715
-
Imaging biomarkers in immunotherapy
-
Juergens RA, Zukotynski KA, Singnurkar A, Snider DP, Valliant JF, Gulenchyn KY. Imaging biomarkers in immunotherapy. Biomark Cancer. 2016; 8:1-13
-
(2016)
Biomark Cancer
, vol.8
, pp. 1-13
-
-
Juergens, R.A.1
Zukotynski, K.A.2
Singnurkar, A.3
Snider, D.P.4
Valliant, J.F.5
Gulenchyn, K.Y.6
-
85
-
-
81055130102
-
Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging
-
Aarntzen EH, Srinivas M, De Wilt JH, Jacobs JF, Lesterhuis WJ, Windhorst AD, Troost EG, Bonenkamp JJ, van Rossum MM, Blokx WA, Mus RD, Boerman OC, Punt CJ, et al. Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging. Proc Natl Acad Sci U S A. 2011; 108:18396-18399
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 18396-18399
-
-
Aarntzen, E.H.1
Srinivas, M.2
De Wilt, J.H.3
Jacobs, J.F.4
Lesterhuis, W.J.5
Windhorst, A.D.6
Troost, E.G.7
Bonenkamp, J.J.8
van Rossum, M.M.9
Blokx, W.A.10
Mus, R.D.11
Boerman, O.C.12
Punt, C.J.13
-
86
-
-
84958953141
-
An effective immuno-pet imaging method to monitor cd8-dependent responses to immunotherapy
-
Tavare R, Escuin-Ordinas H, Mok S, McCracken MN, Zettlitz KA, Salazar FB, Witte ON, Ribas A, Wu AM. An effective immuno-pet imaging method to monitor cd8-dependent responses to immunotherapy. Cancer Res. 2016; 76:73-82
-
(2016)
Cancer Res
, vol.76
, pp. 73-82
-
-
Tavare, R.1
Escuin-Ordinas, H.2
Mok, S.3
McCracken, M.N.4
Zettlitz, K.A.5
Salazar, F.B.6
Witte, O.N.7
Ribas, A.8
Wu, A.M.9
-
87
-
-
84929191608
-
Noninvasive imaging of immune responses
-
Rashidian M, Keliher EJ, Bilate AM, Duarte JN, Wojtkiewicz GR, Jacobsen JT, Cragnolini J, Swee LK, Victora GD, Weissleder R, Ploegh HL. Noninvasive imaging of immune responses. Proc Natl Acad Sci U S A. 2015; 112:6146-6151
-
(2015)
Proc Natl Acad Sci U S A
, vol.112
, pp. 6146-6151
-
-
Rashidian, M.1
Keliher, E.J.2
Bilate, A.M.3
Duarte, J.N.4
Wojtkiewicz, G.R.5
Jacobsen, J.T.6
Cragnolini, J.7
Swee, L.K.8
Victora, G.D.9
Weissleder, R.10
Ploegh, H.L.11
-
88
-
-
84938820449
-
Immuno-PET of murine T cell reconstitution postadoptive stem cell transplantation using anti-CD4 and anti-CD8 Cys-diabodies
-
Tavare R, McCracken MN, Zettlitz KA, Salazar FB, Olafsen T, Witte ON, Wu AM. Immuno-PET of murine T cell reconstitution postadoptive stem cell transplantation using anti-CD4 and anti-CD8 Cys-diabodies. J Nucl Med. 2015; 56:1258-1264
-
(2015)
J Nucl Med
, vol.56
, pp. 1258-1264
-
-
Tavare, R.1
McCracken, M.N.2
Zettlitz, K.A.3
Salazar, F.B.4
Olafsen, T.5
Witte, O.N.6
Wu, A.M.7
-
89
-
-
84988952589
-
Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients
-
Kirilovsky A, Marliot F, El Sissy C, Haicheur N, Galon J, Pages F. Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients. Int Immunol. 2016; 28:373-382
-
(2016)
Int Immunol
, vol.28
, pp. 373-382
-
-
Kirilovsky, A.1
Marliot, F.2
El Sissy, C.3
Haicheur, N.4
Galon, J.5
Pages, F.6
-
90
-
-
84924559749
-
Inflammasome in platelets: allying coagulation and inflammation in infectious and sterile diseases?
-
Hottz ED, Monteiro AP, Bozza FA, Bozza PT. Inflammasome in platelets: allying coagulation and inflammation in infectious and sterile diseases? Mediators Inflamm. 2015; 2015:435783
-
(2015)
Mediators Inflamm
, vol.2015
-
-
Hottz, E.D.1
Monteiro, A.P.2
Bozza, F.A.3
Bozza, P.T.4
-
91
-
-
84940202183
-
Platelets at the interface of thrombosis, inflammation, and cancer
-
Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood. 2015; 126:582-588
-
(2015)
Blood
, vol.126
, pp. 582-588
-
-
Franco, A.T.1
Corken, A.2
Ware, J.3
-
92
-
-
84929342210
-
Antagonists of PD-1 and PD-L1 in cancer treatment
-
Lipson EJ, Forde PM, Hammers HJ, Emens LA, Taube JM, Topalian SL. Antagonists of PD-1 and PD-L1 in cancer treatment. Semin Oncol. 2015; 42:587-600
-
(2015)
Semin Oncol
, vol.42
, pp. 587-600
-
-
Lipson, E.J.1
Forde, P.M.2
Hammers, H.J.3
Emens, L.A.4
Taube, J.M.5
Topalian, S.L.6
-
93
-
-
84962597965
-
The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis
-
Aguiar PN, Jr., Santoro IL, Tadokoro H, de Lima Lopes G, Filardi BA, Oliveira P, Mountzios G, de Mello RA. The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis. Immunotherapy. 2016; 8:479-488
-
(2016)
Immunotherapy
, vol.8
, pp. 479-488
-
-
Aguiar, P.N.1
Santoro, I.L.2
Tadokoro, H.3
de Lima Lopes, G.4
Filardi, B.A.5
Oliveira, P.6
Mountzios, G.7
de Mello, R.A.8
-
94
-
-
84953885167
-
PD-L1 expression as a potential predictive biomarker
-
Fusi A, Festino L, Botti G, Masucci G, Melero I, Lorigan P, Ascierto PA. PD-L1 expression as a potential predictive biomarker. Lancet Oncol. 2015; 16:1285-1287
-
(2015)
Lancet Oncol
, vol.16
, pp. 1285-1287
-
-
Fusi, A.1
Festino, L.2
Botti, G.3
Masucci, G.4
Melero, I.5
Lorigan, P.6
Ascierto, P.A.7
-
95
-
-
84865750471
-
The expression, function, and clinical relevance of B7 family members in cancer
-
Seliger B, Quandt D. The expression, function, and clinical relevance of B7 family members in cancer. Cancer Immunol Immunother. 2012; 61:1327-1341
-
(2012)
Cancer Immunol Immunother
, vol.61
, pp. 1327-1341
-
-
Seliger, B.1
Quandt, D.2
-
96
-
-
84962003766
-
High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis
-
Finkelmeier F, Canli O, Tal A, Pleli T, Trojan J, Schmidt M, Kronenberger B, Zeuzem S, Piiper A, Greten FR, Waidmann O. High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis. Eur J Cancer. 2016; 59:152-159
-
(2016)
Eur J Cancer
, vol.59
, pp. 152-159
-
-
Finkelmeier, F.1
Canli, O.2
Tal, A.3
Pleli, T.4
Trojan, J.5
Schmidt, M.6
Kronenberger, B.7
Zeuzem, S.8
Piiper, A.9
Greten, F.R.10
Waidmann, O.11
-
97
-
-
84907497893
-
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
-
Rossille D, Gressier M, Damotte D, Maucort-Boulch D, Pangault C, Semana G, Le Gouill S, Haioun C, Tarte K, Lamy T, Milpied N, Fest T; Groupe Ouest-Est des Leucémies et Autres Maladies du Sang. High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial. Leukemia. 2014; 28:2367-2375
-
(2014)
Leukemia
, vol.28
, pp. 2367-2375
-
-
Rossille, D.1
Gressier, M.2
Damotte, D.3
Maucort-Boulch, D.4
Pangault, C.5
Semana, G.6
Le Gouill, S.7
Haioun, C.8
Tarte, K.9
Lamy, T.10
Milpied, N.11
Fest, T.12
-
98
-
-
84920956735
-
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
-
Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, Gordon MS, Sosman JA, McDermott DF, Powderly JD, Gettinger SN, Kohrt HE, Horn L, Lawrence DP, et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature. 2014; 515:563-567
-
(2014)
Nature
, vol.515
, pp. 563-567
-
-
Herbst, R.S.1
Soria, J.C.2
Kowanetz, M.3
Fine, G.D.4
Hamid, O.5
Gordon, M.S.6
Sosman, J.A.7
McDermott, D.F.8
Powderly, J.D.9
Gettinger, S.N.10
Kohrt, H.E.11
Horn, L.12
Lawrence, D.P.13
-
99
-
-
84940372582
-
The next hurdle in cancer immunotherapy: overcoming the non-T-cell-inflamed tumor microenvironment
-
Gajewski TF. The next hurdle in cancer immunotherapy: overcoming the non-T-cell-inflamed tumor microenvironment. Semin Oncol. 2015; 42:663-671
-
(2015)
Semin Oncol
, vol.42
, pp. 663-671
-
-
Gajewski, T.F.1
-
100
-
-
84920956732
-
PD-1 blockade induces responses by inhibiting adaptive immune resistance
-
Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, West AN, Carmona M, Kivork C, et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature. 2014; 515:568-571
-
(2014)
Nature
, vol.515
, pp. 568-571
-
-
Tumeh, P.C.1
Harview, C.L.2
Yearley, J.H.3
Shintaku, I.P.4
Taylor, E.J.5
Robert, L.6
Chmielowski, B.7
Spasic, M.8
Henry, G.9
Ciobanu, V.10
West, A.N.11
Carmona, M.12
Kivork, C.13
-
101
-
-
84969257302
-
Assessment of EGFR mutation status in matched plasma and tumor tissue of NSCLC patients from a Phase I study of rociletinib (CO-1686)
-
Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, West AN, Carmona M, Kivork C, et al. Assessment of EGFR mutation status in matched plasma and tumor tissue of NSCLC patients from a Phase I study of rociletinib (CO-1686). Clin Cancer Res. 2016; 22:2386-2395
-
(2016)
Clin Cancer Res
, vol.22
, pp. 2386-2395
-
-
Tumeh, P.C.1
Harview, C.L.2
Yearley, J.H.3
Shintaku, I.P.4
Taylor, E.J.5
Robert, L.6
Chmielowski, B.7
Spasic, M.8
Henry, G.9
Ciobanu, V.10
West, A.N.11
Carmona, M.12
Kivork, C.13
-
102
-
-
85024394279
-
-
FDA. http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm504540.htm
-
-
-
|